EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Common and varied molecular responses of Escherichia coli to five different inhibitors of the lipopolysaccharide biosynthetic enzyme LpxC

Anna-Maria Möller, Melissa Vázquez-Hernández, Blanka Kutscher, Raffael Brysch, Simon Brückner, Emily C Marino, Julia Kleetz, Christoph H R Senges, Sina Schäkermann, Julia E Bandow, Franz Narberhaus

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Anna-Maria Möller und 10 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Amidohydrolases, Enzyme Inhibitors, Escherichia coli. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, North Rhine-Westphalia State Ministry of Innovation Science Research and Technology, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A promising yet clinically unexploited antibiotic target in difficult-to-treat Gram-negative bacteria is LpxC, the key enzyme in the biosynthesis of lipopolysaccharides, which are the major constituents of the outer membrane. Despite the development of dozens of chemically diverse LpxC inhibitor molecules, it is essentially unknown how bacteria counteract LpxC inhibition. Our study provides comprehensive insights into the response against five different LpxC inhibitors. All compounds bound to purified LpxC from Escherichia coli. Treatment of E. coli with these compounds changed the cell shape and stabilized LpxC suggesting that FtsH-mediated proteolysis of the inactivated enzyme is impaired. LpxC inhibition sensitized E. coli to vancomycin and rifampin, which poorly cross the outer membrane of intact cells. Four of the five compounds led to an accumulation of lyso-phosphatidylethanolamine, a cleavage product of phosphatidylethanolamine, generated by the phospholipase PldA. The combined results suggested an imbalance in lipopolysaccharides and phospholipid biosynthesis, which was corroborated by the global proteome response to treatment with the LpxC inhibitors. Apart from LpxC itself, FabA and FabB responsible for the biosynthesis of unsaturated fatty acids were consistently induced. Upregulated compound-specific proteins are involved in various functional categories, such as stress reactions, nucleotide, or amino acid metabolism and quorum sensing. Our work shows that antibiotics targeting the same enzyme do not necessarily elicit identical cellular responses. Moreover, we find that the response of E. coli to LpxC inhibition is distinct from the previously reported response in Pseudomonas aeruginosa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmidohydrolasesEnzyme InhibitorsEscherichia coliAnti-Bacterial AgentsLipopolysaccharidesPseudomonas aeruginosaDrug Resistance, BacterialCell Membrane

Stichwörter der Autor:innen

FtsHLPSantibioticslipopolysaccharideouter membranephospholipidproteomics

Substanzen

AmidohydrolasesAnti-Bacterial AgentsEnzyme InhibitorsLipopolysaccharidesUDP-3-O-acyl-N-acetylglucosamine deacetylase

Autor:innen und Institutionen

  • Microbial Biology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.
  • Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.
  • Microbial Biology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. Electronic address: franz.narberhaus@rub.de.

Förderung

  • Deutsche Forschungsgemeinschaft
  • North Rhine-Westphalia State Ministry of Innovation Science Research and Technology
  • European Commission
  • European Regional Development Fund

Zitieren

APA

Möller, A. M., Vázquez-Hernández, M., Kutscher, B., Brysch, R., Brückner, S., Marino, E. C., Kleetz, J., Senges, C. H. R., Schäkermann, S., Bandow, J. E., & Narberhaus, F. (2024). Common and varied molecular responses of Escherichia coli to five different inhibitors of the lipopolysaccharide biosynthetic enzyme LpxC. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107143

Vancouver

Möller AM, Vázquez-Hernández M, Kutscher B, Brysch R, Brückner S, Marino EC, et al. Common and varied molecular responses of Escherichia coli to five different inhibitors of the lipopolysaccharide biosynthetic enzyme LpxC. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107143

BibTeX
@article{Mller2024,
  author = {Möller, Anna-Maria and Vázquez-Hernández, Melissa and Kutscher, Blanka and Brysch, Raffael and Brückner, Simon and Marino, Emily C and Kleetz, Julia and Senges, Christoph H R and Schäkermann, Sina and Bandow, Julia E and Narberhaus, Franz},
  title = {Common and varied molecular responses of Escherichia coli to five different inhibitors of the lipopolysaccharide biosynthetic enzyme LpxC},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107143}
}
Kostenlos starten →